← Eichor
Study identifier: NCT04813705 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Condition: Nasopharyngeal Carcinoma  ·  Sponsor: Taizhou Hospital

PhasePhase 2
Planned participants93
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to explore whether 18F-FDG PET/CT guided reduced-dose radiotherapy would maintain survival outcomes in nasopharyngeal carcinoma (NPC) patients.

This description comes directly from the study's public registry record.

Talk to the study team

Haihua Yang, MD  ·  13819639006  ·  yhh93181@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (4)

Taizhou Central HospitalTaizhou, Zhejiang, ChinaRecruiting
Taizhou HospitalTaizhou, Zhejiang, ChinaRecruiting
Taizhou Cancer HospitalTaizhou, Zhejiang, ChinaRecruiting
Taizhou Enze Medical Center(Group) Enze HospitalTaizhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04813705